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Objective: A calvarial defect model was used to study the effect of additions of osteoblasts 
in both a grid culture and implantation onto chick embryo membrane. The secondary aim 
was to study the effects of resolvins D4 and D5, parathyroid hormone and ascorbic acid on 
collagen synthesis and cell differentiation.  
Methods: A mouse calvaria critical defect model was used in both an in-vitro and ex-vivo 
cultures. Calcium uptake was measured by an Arsenazo III microplate assay. Neutral Red 
and H&E staining were used for histological analysis.  
Results: There was no significant difference is observed between groups supplemented 
with osteoblasts and those without. Addition of D4 and D5 decreased macrophage numbers 




Discussion: Osteoblasts require a specific environment and nutrition in order to survive 
and synthesize bone matrix in a defect or injured area. D4 and D5 resolvins may be able to 
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The Function of Bone 
The exoskeleton in vertebrates is an evolutionary divergence from the endoskeleton 
in chordates, providing more movement ability and more potential for growth4. The 
skeleton soon became a source of stress and injury. An initial insult would lead to a 
cascade of cell interactions leading to ordered and organized healing51. The skeletal system 
provides internal support and protection of vital organs and acts as an active storage site 
for biominerals.  Bone provides a medium for blood cell production, is a calcium and 
phosphate reservoir, aids in movement, and provides structural support24. Plasma calcium 
concentration is typically maintained between 9-10 mg/dL with contributions from 
kidneys, intestinal epithelium, and parathyroid hormone (PTH). Phosphate is found in two 
ionic form types, H2PO4 and HPO4 at 0.26 mmol/L and 1.05 mmol/L respectively.  
Phosphate ion is mainly regulated through the kidney as a threshold ion32. Red and white 
blood cells come directly from bone marrow, and stroma cells provide precursors for 
osteoblasts and hematopoietic stems cells for osteoclasts. Coupling of bone-forming 
osteoblasts and bone-resorbing osteoclasts allow for dynamic changes in structure, volume, 
strength, and overall integrity of the organ53. Bone lining cells and osteocytes help regulate 
bone metabolism and play a significant role in maintenance. Bone is one of the most 
important connective tissues and it is made up of 70% inorganic components, 20% organic 
components, and 10% water. The organic component is mostly type I collagen. 
Noncollagenous proteins found in the bone matrix include fibronectin, osteonectin, 




Figure 1: Bone anatomy, micro and macrostructure (OpenStar_College 2017). 
 
Bone Cells 
 Osteocytes make up about 90% of bone cells and can live up to 25 years. The 
location contributes to their morphology. Osteocytes are found in lacunae of mineralized 
tissue. Cortical bone osteocytes will demonstrate a stretched or dendritic-type versus a 
round morphology for those in trabecular bone. As osteoblasts sythesize bone matrix, they 
become entrapped as osteocytes in the bony matrix. Then the size changes and the nucleus 
cytoplasm ration increases. A reduction in organelles leads to decreased protein 
production. Cell processes extend into channels called canaliculi. These extensions allow 
for communication with other osteocytes through the lacunocanalicular network and allow 
cells to respond to various stimuli. Cells responsible for resorption of bone are osteoclasts, 
a specialized multinucleated cell from the hematopoietic pathway. Regulation of 
expression of the genes responsible for osteoclast action depend on factors such as receptor 
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activator of nuclear factor kappa-Β ligand (RANK-L), macrophage colony-stimulating 
factor (M-CSF), and osteoprotegrin (OPG). M-CSF will lead to osteoclast replication while 
RANK-L binding to RANK will stimulate differentiation of osteoclasts from osteoclast 
precursors. OPG will bind with RANK-L and prevent RANK-L and RANK binding. When 
osteoclasts are active, the cells become polarized and a ruffled border binds to the bone 
matrix. Acids are secreted that demineralize and enzymes are released that degrade bone 
matrix. The recruitment and action of these powerful cells are of interest in treatment of 
inflammatory-mediated diseases such as periodontitis and osteoporosis32.  
 







Figure 3: Bone cell communication. Damage to cell-cell cytoplasmic junction will 
disrupt signaling via circumferential lamellar, Haversian, and Volkmann canals 
(Lieberman et al. 2005). 
 
Osteoblasts 
These cells are of significant interest, in that they synthesize components of the 
bone matrix, regulate mineral composition, and have a major role in regeneration of bone. 
Morphological characteristics of an active secretory cell include plentiful rough 
endoplasmic reticulum, secretory vesicles, and a significant Golgi apparatus23. Surface 
osteoblasts (SOBL) and mesenchymal osteoblasts (MOBL) are responsible for nearly all 
bone formation53.  Osteoblasts that originate either from neuroectoderm or from 
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mesenchymal progenitors will form bones via intramembranous ossification. Endochondral 
ossification occurs when osteoblasts differentiate from chondrocytes or perichondral cells. 
Mesenchymal stem cells (MSCs) will give rise to either adipocytes, osteoblasts, myoblasts, 
fibroblasts, or chondroblasts. Regulators of expression of differentiation genes include 
PPARγ, Runx2, MyoD, and Sox9, and are unique to each respective lineage. A 
combination of Sox9, Msx2, and Hedgehog signaling can direct stem cells to an 
osteoblastic cell line. The initiator of osteoblast cell lineage is a result of an amalgamation 
of signals from factors including bone morphogenetic proteins (BMPs) and transforming 
growth factor beta (TGF-β)-like molecules. Proteins that are key in embryological 
development, such as noggin, can inhibit BMPs. When the proper receptor-ligand 
interaction is made, a Smad complex transports the message to the nucleus. The Runx-2 
gene, encodes Runx-2 protein and leads to activation of osteoblast differentiation. 
Endocrine and paracrine factors also will affect osteoblastic differentiation. Some of those 
factors include vitamin D, PTH, BMPs, insulin-like growth factor (IGF), fibroblast growth 
factor (FGF), interleukins (IL-11), and histone deacetylases (HDACs). Modification of 
histones will affect transcriptional activity and thus will have powerful downstream 
effects49. A study by Komori et al. in 1998 demonstrated that there was no osteoblast 
formation in homozygous -Runx-2 mice32 .Osteocalcin is a protein secreted only by 
osteoblasts and is the second most abundant protein aside from collagen in bone49. 
Modification of glutamic acid to gamma carboxyglutamic acid of osteocalcin favors 
calcium ion binding. Serum osteocalcin levels may be used as an indicator of osteoblastic 




Figure 4: HE-stained trabecula (B), polarized osteoblasts (Ob), multinucleated 
osteoclasts (Oc), and osteocytes (Ot) found in bony matrix. 
 
Bone Formation 
Biomarkers found during bone formation, include bone sialoprotein (BSP), 
osteopontin, alkaline phosphatase (ALP), and BMP2. A culture media that is osteogenic or 
promotes osteogenesis can include dexamethasone, ascorbic acid, and b-glycerophosphate.    
Bone tissue is either formed by intramembranous or endochondral formation. 
Intramembranous formation of bone does not require a cartilage precursor. Instead, the 
bone forming cells on the inner cambium layer of the periosteum coalesce and secrete 
osteoid directly. Endochondral bone formation uses a cartilage precursor as a scaffold for 
bone formation and mineralization. Both mechanisms lead to the same bone formation. 
Type I collagen is synthesized by osteoblasts and is the main protein in bone. Until 
maturity, long bones are growing proportionally with diaphysis elongating and epiphyses 
and metaphysis becoming more distant from one another. Epiphyses have cartilage origins 
and three different regions. Articular cartilage, metaphysis, and epiphysial cartilage are 
distinct histologically and have unique functions. The growth plate, or metaphysis, will be 
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invaded by osteoprogenitor cells and vasculature accompanied by cell replication and 
hypertrophy, synthesis, and mineralization of matrix53. There are two structure types of 
bone, lamellar and woven bone. Woven bone is characterized by an unorganized or 
random orientation of collagen. Lamellar bone will have osteoid parallel to each other with 
a characteristic orthogonal pattern. In an environment devoid of bone tissue, MOBLs will 
differentiate to pre-osteoblasts and then osteoblasts. These cells will secrete collagen 
creating a net or scaffold. Then SOBLs will use this scaffold as a path to secrete collagen 
fibrils on the existing network and will create a lamellar pattern of hard tissue matrix. 
When fully surrounded by its own created and adjacent mineralized tissues, an osteoblast 
is trapped and becomes an osteocyte53. Collagen type I, ALP, OCN, and BSP are then 
downregulated. Osteocyte markers are upgraded23. Cell conformation and morphology will 
be dependent on location and type of bone.  
 
Resolvins and Wound Healing 
Heat, redness, pain, and swelling are classic signs of inflammation that can occur 
when the body is subjected to insult or injury or chemicals from the environment. It can 
also seek out the body’s own cells in a failure to recognize ‘self’ in autoimmune or 
immune-mediated conditions. ω-3 polyunsaturated fatty acids and their clinical and 
supplemental have been a topic of contention for years now. Resolvins are bioactive and 
derived from the omega-3 polyunsaturated fatty acids and their role in suppression of 
inflammation have been a study for years. Resolvins are derived from omega-3 
polyunsaturated fatty acids, eicosapentaenoic acid and docasahexaenoic acid, are termed E-
series and D-series resolvins. A variety of benefits of omega-3 polyunsaturated fatty acids 
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include improved diabetic wound healing, improved symptoms and pain management in 
rheumatoid arthritis, and even suppression of osteoclast differentiation and resorption of 
bone. Hasturk et al. demonstrated the effects of resolvins in a P. gingivalis-induced 
periodontitis model in rabbits. Leukotriene B4, prostaglandin E2-treated groups, along with 
a vehicle control group were compared to the resolvin group. Disease progression and 
severity was apparent in the leukotriene and prostaglandin group, while the resolvin group 
had near complete resolution of inflammation. As a result, soft and hard tissues were 
restored26. D-series resolvins are derived from docosahexaenoic acid, a precursor that is 
locally accumulated at areas of injury and repair. Management of local inflammatory 
response is important in interventional care, such as surgery. In a mouse second organ 
injury model, RvD4 demonstrated reduced PMN infiltration in the lungs compared to the 
control. It reduced levels of proinflammatory mediators such as prostaglandin and 
thromboxane. Excessive inflammation, collateral tissue damage, and organ injury are 
dampened by RvD4’s direct and downstream effectors61. In another study in collaboration 
with Brigham and Women’s Hospital and Harvard Medical School, D4 resolvins 
demonstrated an organ protective effect in a reperfusion injury model60. 
 




Figure 6: Resolvin D5 (Cayman Chemical) 
 
In-Vitro Model 
Critical defect is a type of bone loss that is not capable of spontaneous healing. 
Biomaterials leading to full regeneration and healing is the magic bullet clinicians would 
like to have52. This study utilizes a design used in the Boston University Periodontology 
Graduate program. A stainless steel mesh grid with crimped legs allowed for elevation of 




 Chick embryos provide a unique nutrient supply to a calvaria compared to 
experimental media. Chorioallantoic membrane (CAM) has been used to study 
angiogenesis.  Blood vessels rapidly develop in the first 10 days, providing a capillary 
plexus. This plexus allows for gas exchange with the environment and is part of the surface 
of the ectoderm, close to the shell membrane. CAM extracellular matrix has distinct 
changes in gene expression, including increased levels of fibronectin in early stages of 
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development before development of a capillary plexus. Laminin is present throughout all 
steps of vessel formation while type IV collagen is present at the later stages along with 
terminal differentiation of the basement membrane and endothelial cells47.  
 
 Ascorbic Acid and Parathyroid Hormone  
These two are key local and systemic factors that affect bone matrix formation and 
homeostasis. Factors like these have paracrine, endocrine and autocrine signaling 
pathways23. Diet with adequate levels of sodium, phosphorus, calcium, vitamin C, and 
vitamin D are associated with bone formation. Vitamin C can gather free radicals and 
reactive oxygen species (ROS). It is also an important cofactor for lysyl and prolyl 
hydroxylases, enzymes necessary for collagen synthesis. Vitamin C has been shown to 
prevent decreased bone density (BMD). Addition of vitamin C to osteoblast or osteoblast-
like cell cultures will increase collagen synthesis as well as prevent loss of the osteoblast 
differentiation markers BMP-2, Runx-2, and osteocalcin. Vitamin-C supplements given to 
deficient mice result in a decreased expression of RANKL, thus favoring 
osteoblastogeneis. In an in vivo model of osteoporosis, ovariectomized (OVX) rats 
demonstrated decreased bone density and calcium content. Vitamin C supplementation 
allowed the animals to recover. Those without had increased expression of osteoclast 
favoring genes13. Parathyroid hormone (PTH) has anabolic effects on mouse calvaria and a 
negative effect on collagen expression (Dose*). Mediators such as OPN and BSP will have 




Figure 7: Effects of Vitamin C on Osteoblastogenesis and Osteoclastogenesis (Choi et 







STUDY AIMS AND NULL HYPOTHESIS 
The aim of this study was to determine the effect of osteoblast addition and 
collagen scaffold-mediated repair of calvarial defects in a grid and ex vivo chick embryo 
model. The secondary aim was to study the effects of resolvin D4 and D5, parathyroid 
hormone and ascorbic acid on collagen synthesis and cell differentiation. Our hypothesis is 
that osteoblasts seeded on a collagen scaffold over a critical defect in calcium 
supplemented media will demonstrate increased cell differentiation and bone formation 
compared to the calcium supplemented media control. Secondary, our hypothesis is that 
D4, D5, and ascorbic acid will favor osteoblastogeneis compared to parathyroid hormone.   
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MATERIALS AND METHODS 
Alpha MEM (aMEM) 
Alpha Modified Minimum Essential Medium (GibcoTM) was primarily used for 
osteoblast cell culture. The correct tissue culture media is essential for osteoblast cell 
proliferation and viability, and aMEM allows for adequate nutritional support and more 
potential biomineralization in vitro. Compared to other similar media, such as DMEM, 
aMEM contains higher levels of amino acids and protein content similar to that of cells. 
Osteoblast cell cultures with aMEM can mineralize 2-3 days sooner compared to DMEM 
fed cultures40. The product catalog lists non-essential amino acids, ascorbic acid, lipoic 
acid, sodium pyruvate, biotin, and vitamin B12. Additions can include 1% Penicillin-
Streptomycin solution (5000 u/mL Penicillin, 5 mg/mL and Streptomycin, (GibcoTM). 
 
Dulbecco’s Modified Eagle Medium (DMEM 
  
DMEM is another widely used medium in mammalian cell culture. It lacks the 
additions mentioned above for aMEM but includes glucose (1 g/L) and sodium pyruvate. 
DMEM is buffered with sodium bicarbonate (3.7 g/L). For the purposes of this study, 
DMEM was supplemented with ascorbic acid (vitamin C) and 1% PenStrep unless used a 
wash solution for cell isolation. Both media were carefully managed and stored with tight 
seals to maintain adequate temperature control (stable for four weeks at 4° C) and pH, 







 Salvin® OraTape was used for this experiment. Mainly composed of type I 
collagen, this material is biocompatible and has good handling characteristics. The 
collagen membrane serves as a scaffold for osteoblasts and increases the potential for bone 
formation. The material is sterile in packaging and a 2mm punch was used to create 
standardized scaffolds to be placed in the 2mm critical defect.  
 
Figure 8: Salvin® Collagen Tape. 
 
Ascorbic acid 
 Also well-known as Vitamin C, L-ascorbic acid is key in collagen synthesis and 
biomineralization. Ascorbic acid, a water-soluble vitamin, is essential in collagen 
synthesis. Lack of ascorbic acid will lead to deficiency in collagen synthesis. In adequate 
concentration, it can accelerate wound healing, specifically reducing oxidative stress and 
accelerating bone healing18. 
 
Neonatal Calvaria Harvest Procedure 
Procedures described were approved by Institute of Animal Care and Use 
Committee (Title: Studies of Factors that affect bone remodeling In Ex-vivo Neonatal 
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Mouse Calvarial Bone Organ Cultures- PROTO20180019). CD-1 mice, 5-7 days old were 
purchased from Charles River Laboratories, MA. Harvesting of calvaria was done under 
sterile conditions. Following cervical dislocation to sacrifice each animal. Ethanol 70% 
was sprayed over external tissues as a disinfectant. Sterile surgical scissors were used to 
cut the nape. Incision was extended from nape occipital area to frontal bone. Soft tissue 
was then carefully peeled with forceps carefully so as to not damage the calvaria. Once the 
calvaria was exposed a cut was made at the occipital bone and trimmed to frontal bone.  
Brain tissue was removed from the underside of calvaria. Excess soft tissues were trimmed 
and individual calvaria were washed with DMEM media with 1% PenStrep. Then steps 
were repeated for 10 total calvaria. 
 
Osteoblast Isolation 
 10 harvested calvaria were placed into a single 15 mL Falcon Tube and washed 
with 5 mL phosphate buffered saline (PBS) (GibcoTM) to remove any soft tissue remaining 
on calvaria surface. The PBS was discarded and 0.25% trypsin (500 µL/calvaria) was 
added to the 15 mL tube and allowed to incubate at 37° C for 10 minutes. The trypsin was 
discarded and the calvaria were washed with aMEM. A 0.2% collagenase solution was 
prepared by adding 20mg powdered collagenase added to 10 mL aMEM. 5 mL 0.2% 
collagenase was added to tube and incubated at 37° C for 10 minutes. This collagenase 
digest was discarded, and an additional 5 mL collagenase solution was added for 
incubation at 37° C for 60 minutes. The final digest was retained. The residual calvaria was 
washed with 5 mL aMEM and added to final digest, ready for centrifugation at 2000 rpm 
for 5 minutes. The supernatant was removed and the pellet was resuspended with 10 mL 
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aMEM (1 mL/ calvaria). Cells were counted and split onto 4 plates (average count 2.7x106 
cells/ 10 mL) with each plate containing ~100,000 cells/mL solution (1.85 mL cell 
solution/plate + 3.15 mL aMEM). Plates were placed in incubator at 37° C, with culture 
media changed every 2-3 days. Cells were passed when confluent, allowing for 
multiplication for use in later experiments. Remaining cells not included in plating 
incubation were stored frozen into 2 Eppendorf tubes (containing 1.3 mL cells + 5% 
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DMSO 0.195 mL). 
  
Figure 9: Osteoblast morphology and attachment 4x magnification. 
   
 
 
Osteoblast cell attachment  




 Osteoblasts were checked for confluence and attachment to the cell culture plate. 
One plate of fully attached osteoblasts were split to three plates. Media was removed and 
discarded. Cells are washed with DMEM media with 5 mL/mg BSA. 5 mL trypsin is added 
to the cell layer, and cell detachment was monitored microscopically. After all cells were 
detached, the media was transferred into a 50 mL falcon tube and centrifuged at 2500 rpm 
to pellet. The supernatant was discarded, and the pellet was resuspended with 45 mL 
aMEM. The cells were gently manually mixed, and 15 mL of media with cells were 
transferred into one cell culture plate, 3 plates total. Cell culture placed in 37° C incubator 
and the media changed every 2-3 days.  
 
Cell Counting 
 Confluent cells were selected for a cell count. One plate was chosen from the line 
of 3 plates. The same protocol was used to detach cells from the cell culture plate. Cells 
were resuspended in 1.5 mL DMEM. 10 µL of the suspension were pipetted onto 
hemocytometer and cells were counted based on calculation.  
 
Calcium Assay 
 Cells in Eppendorf tubes were thawed and centrifuged at 2500 rpm for 5 minutes. 
The supernatant was removed and placed in a new Eppendorf tube. The pellet was 
suspended in 0.5 mL Triton. Vortexed, and allowed to sit for one hour then centrifuged at 
3000 rpm for 5 minutes. The supernatant was removed and stored at -40° C. The remaining 
pellet was suspended in 100 µL 0.1 M HCL, then neutralized with 20 µL 0.5 M NaOH and 
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centrifuged at 3000rpm for 5 minutes. The supernatant was used and the pellet discarded. 
A 96-well plate with flat bottom and cover was used for the calcium assay. Twenty µL of 
sample was placed in duplicates wells, the first two wells were used as controls and 
contained only calcium stock. 180 µL complexon and ammonium bicarbonate buffer was 
added to each well containing sample. The first 7 duplicates were reserved for a standard 
dilutions of calcium stock in decreasing concentrations. Calcium levels were measured in a 
Vector 3 plate reader at 560 nm setting for 0.1 seconds, and the data was exported.  
 
Neutral Red Staining 
 Selected wells were stained with 70 μg/ml Neutral red. Calvaria and media + NR 
were incubated at 37° C for 45 minutes. Samples were then visualized microscopically at 
4x, 10x, and 20x magnifications, and photographed. The calvaria were removed from NR 
media after photographs were taken and prepared for histology.  
 
In-Vitro Osteoblast Culture (2D) 
 Calvaria were harvested and incubated for 48 hours in culture media prior to 
producing the critical defect and starting the experiment. A 2mm tissue punch was used to 
create a standardized defect in each parietal bone. The punch defect was made with the 
calvaria up-side down to avoid crushing the parietal bone. The same tissue punch was used 
to create a collagen plug implant which could be seeded with osteoblast cells or media 
only. The collagen was carefully placed into the defect before the seeding. The calvaria 
with defect and collagen were then placed on triangular stainless steel mesh rafts into 6-
well plates. 2 mL culture media with additions appropriate to each experiment (ascorbic 
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acid media, Parathyroid hormone, D3 resolvin, D4 resolvin) was added to each well to the 
level of the calvaria on the raised metal mesh. The calvaria were never fully immersed or 
submerged in media. No tissue punch was done in the resolvin portion of experiments. 
 






















Figure 12: Closer view of individual well with calvaria and metal mesh grid. 
 
  
Ex-Vivo Calvaria model (3D) 
 Calvaria preparation was the same until implantation on chick embryo. Fertilized 
chicken eggs were incubated at 37° C and 70% humidity. The eggs were rotated 90° from 
original position every day for one week. An egg candler was used to visualize the chick 
embryo and vasculature. Two holes were then created with BrasslerTM  size 6 round bur 
with foot pedal-controlled rpm. One small hole was created at the airspace to allow for 
insertion of a straw. The other hole was created at the area of the vasculature with care not 
to sever any blood vessels or tear through membranes. Suction through the straw allows 
the amnion membrane to drop, creating a larger air space at the top of the egg. The window 
was then enlarged to allow for placement of calvaria from convex (egg) to concave 
(calvaria) surface for total intimate contact. Clear Scotch tape was used to cover the 
created window, and black nail polish was used to cover smaller hole. Each egg carried 1-2 
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calvaria. Incompletely developed embryos were discarded. All eggs with calvaria were 
then placed back in 37° C incubator for 10 days. Water was added as needed to maintain 
proper humidity throughout 10 days. At the termination of the experiment, the calvaria was 
carefully trimmed away along with attached underlying amniotic membrane and 
vasculature. Calvaria were then prepared for histology and the chicks were sacrificed. 
 




Figure 14: Windowed egg, dropped membrane, chick embryo vasculature.  
 
 






Figure 16: Placing calvaria with critical defect+collagen onto egg membrane. 
 
 
Figure 17: Timeline setup for ex-vivo 3D model. 
 
Histology Preparation 
 Calvaria samples selected for histology were removed from media and placed in 
10% formalin solution for 24 hours. The formalin solution was replaced with 0.1 M HCL 
in amounts sufficient to fully cover calvaria for 30 minutes. The HCL solution was then 
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removed and EDTA tris buffer was then added before labeling and sending to processing 
company. High-resolution images were returned and analyzed.  
 
Experimental Design 
I. Experiment B (n=4 each) 
a. Group 1: Defect with scaffold (Collagen Tape) on grids with osteoblasts 
cells seeded 
b. Group 2: Defect with scaffold (Collagen Tape) on grids without osteoblasts 
cells seeded (only media) 
c. Group 3: Defect with scaffold (Collagen Tape) on chick embryo with 
osteoblasts cells seeded 
d. Group 4: Defect with scaffold (Collagen Tape) on chick embryo without 
osteoblasts cells seeded 
II.  
Experiment C (n=4 each) 
a. Group 1: Defect with scaffold (Collagen Tape) on grids with osteoblasts 
cells seeded 
b. Group 2: Defect with scaffold (Collagen Tape) on grids without osteoblasts 
cells seeded (only media) 
c. Group 3: Defect with scaffold (Collagen Tape) on chick embryo with 
osteoblasts cells seeded 
d. Group 4: Defect with scaffold (Collagen Tape) on chick embryo without 
osteoblasts cells seeded 
 
III. Experiment 1A (n=8 each) 
a. Group 1: Defect with scaffold (Collagen Tape) on grids with osteoblasts 
cells seeded 
b. Group 2: Defect with scaffold (Collagen Tape) on grids without osteoblasts 
cells seeded (only media) 
c. Group 3: Defect with scaffold (Collagen Tape) on chick embryo with 
osteoblasts cells seeded 
d. Group 4: Defect with scaffold (Collagen Tape) on chick embryo without 
osteoblasts cells seeded 
 
IV. Experiment 2A (n=8 each) -repeat of experiment 1A- 
a. 1: Defect with scaffold (Collagen Tape) on grids with osteoblasts cells 
seeded 
b. Group 2: Defect with scaffold (Collagen Tape) on grids without osteoblasts 
cells seeded (only media) 
c. Group 3: Defect with scaffold (Collagen Tape) on chick embryo with 
osteoblasts cells seeded 
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d. Group 4: Defect with scaffold (Collagen Tape) on chick embryo without 
osteoblasts cells seeded 
 
V. Experiment 1C (n=4, 2, 2, 5, 5, 5, 5 respectively) 
a. Group 1: Whole calvaria in PTH media  
b. Group 2: Whole calvaria in D4 media  
c. Group 3: Whole calvaria in D5 media 
d. Group 4: Whole calvaria in D4+PTH media 
e. Group 5: Whole calvaria in D5+PTH media 
f. Group 6: Whole calvaria in D4+AA media 












Initial cell count was done with hemocytometer on first calvaria harvest. The cells 
were suspended in 1 mL media and kept frozen for other experiments that required 
osteoblast seeding, to keep cell counts standardized.  
Calculation: 13.25 x 104 x 5 (trypan blue). 6.3 x 105 cells/mL 
10 x 15 
x x x 
17 x 11 
 
Experiment C 
 There was no statistical significance in cumulative calcium changes, measured in 
micromolar/2mL). Figure 18 demonstrates the standard calcium. Figure 19 demonstrates 





Figure 18: Calcium standard. 
 
Figure 19: Comparison of calcium uptake comparison between group with media vs 
osteoblast seeded calvaria. 
 
  






























 Neutral red staining was done for all groups to observe qualitative changes in 
cellular morphology and proliferation. The first three groups which include supplemented 
PtH demonstrate distinct multinucleated cell response, most pronounced being in PtH 
control group seen in Figure 20. Resolvin D4 and D5 appeared to dampen the 
osteoclastogenic response and overall osteoclast number, observed via microscope. 
Overall, there was no significant difference is observed among the different groups in 
terms of distinct morphological changes or overall proliferation. 
 
Neutral Red Staining 





Figure 20: Neutral red-stained calvaria viewed at 20x 
(From left to right and top to bottom: PtH, D4, D5, 
D4+PtH, D5+PtH, D4+AA, and D5+AA.  
 
Staining done to observe cellular morphology and 
proliferation. More pronounced multinucleated cell observed 
in the PtH only group. AA and D4/D5 resolvin combination 
groups did not show any distinct morphological changes in 




 This experiment utilized the ex-vivo and live chick embryo 3D environment. Each 
group had one subgroup, separated by collagen in critical defect with or without 
osteoblasts. Collagen’s network, or web-like appearance can be appreciated on Figure 21. 
Proliferation of lining-type bone cells appear in both subgroups, seen in Figure 22. 
Osteoblast-seeded group demonstrated osteoblasts in the critical defect area 
undifferentiated in morphology with a round shape. These observations were similar 
between the grid and chick groups. Chick embryo-implanted calvaria demonstrated islands 
of denser cell population at more vascular areas. This observation did not include any 
statistical calculation. In Figure 23, distinct staining difference is seen at the collagen bone 
interface at the critical defect site. The darker purple stain on the collagen matrix, 
transitioning to the purple calcified matrix of calvaria bone. Chorioallantoic membrane is 
seen in Figure 24. Vessels and glandular tissue can be seen along the external surface of 





In a repeat experiment, osteoblasts can be seen on collagen membrane, along with 
increased proliferation of cells near vessels. Cilia at the membrane surface is seen in 
several histological sections. No significant difference can be observed between the 










type network of collagen, 
that allows for ideal 
wound healing and 
potential repopulation of 





Figure 22: Collagen 
















Figure 23: Collagen 




Critical defect junction of 
osteoblast-seeded 











Figure 24: Collagen 
implant in defect of 
calvaria implanted on 
embryo membrane.  
 
Blood vessels can be 
visualized at the top portion 







Figure 25: Collagen 
implant in defect of 
calvaria implanted on 
embryo membrane 
(higher magnification) 
Amnion membrane and 







Figure 26: Collagen implant 
in defect of calvaria 
implanted on embryo 
membrane. (Experiment 2A 
chick embryo without 
osteoblast cells) 
No significant difference 
observed in the group with and 




 The experimental media used in this study cannot fully simulate the 
microenvironment of osteoblasts or that of bone healing. The goal of the study was to 
monitor changes of osteoblast morphology and behavior and changes in calcium uptake. 
This tissue engineering model utilizes a collagen scaffold membrane with addition of 
Vitamin C media with and without osteoblast cell seeding. The osteoblast-seeded group 
did not show any advantage in healing that could be attributed to the addition of cells.  
 Tissue engineering requires a supply of nutrients, a scaffold, and viable cells. The 
scaffold and nutrient supply were controlled in the first set of experiments. Most of the 
cells come from the calvaria itself. The addition of osteoblasts into the scaffold, did not 
result in any significant effect on our measured parameters or histology.  
To supplement the nutritional component, calvaria were implanted on the 
chorioallantoic membrane of fertilized chicken embryos. These embryos demonstrate quite 
rapidly progressing vascularization in just ten days. The robust blood supply from the 
chicken embryo should increase nutrition to the viable cells of the implanted calvaria. 
Previous studies demonstrated an angiogenic response to the calvaria placed on the CAM. 
Angiostatic agents used in those studies inhibited angiogenesis. A major limitation to this 
type of model is the induction of an inflammatory response from the implantation of 
foreign body on the CAM. This would affect the angiogenic response, as a result, 
quantifying specific agents or measuring response will be confounded47. 
The secondary focus was to observe changes in osteoblasts with addition of AA, 
PTH, D4, and D5 media. It was anticipated to see a pro-resolution function of the 
resolvins. Previous studies utilizing a reperfusion model, demonstrated RvD4 reduced 
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PMN and neutrophil infiltration in lung tissues compared to the control60. Although current 
study uses a model without blood circulation, we are able to observe histological 
differences in macrophage presence in the RvD4 and RvD5 groups compared to PTH 
groups.. We observed numerous multinucleated cells in the PTH only group. AA and 
D4/D5 resolvin combination groups did not show any distinct microscopic morphological 
changes in cells. Histological observation demonstrated dampened macrophage response 
with D4 and D5 resolvins addition to culture media but could not be quantified to a 
significant difference. One complication for experimental use of resolvins storage in 
ethanol that will evaporate when a vial is kept open. This will lead to a change in 
concentration of the resolvins and prevent proper dosing. Another source of variation 
might be the number of cells seeded. Cell counts were not done each time frozen cells were 
resuspended and used for seeding collagen implants.  
These considerations are key in future research towards biomaterials and 
individualized stem-cell therapy. Progress in these fields will lead to progress in clinical 
parameters of success in treatment and reconstruction of lost tissues due to disease, trauma, 
or malformation and development.  
 
CONCLUSION  
In this study, there was no statistical support for the hypothesis that osteoblasts 
seeded on a collagen scaffold over a critical defect in calcium supplemented media will 
demonstrate increased cell differentiation and bone formation compared to the calcium 
supplemented media control. There was also a lack of supporting evidence that D4, D5, 
and ascorbic acid will favor osteoblastogeneis compared to parathyroid hormone. Addition 
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of osteoblast cells did not increase collagen synthesis or bone formation. The addition of 
resolvin D4 and D5 demonstrated a reduced macrophage count, although the total sample 
size is too low to draw conclusions about specific response. The ex-vivo model using chick 
chorioallantoic membrane demonstrates increased leukocyte and osteoblast recruitment at 
the areas of vessel supply, such as arteriole. Due to sample size and heterogeneity of the 
chick embryos, no conclusions can be drawn. Changes in osteoblast cell behavior will 
depend on its environment or ‘milieu’ which will have implications in bone health, disease, 
and form. The question naturally arises, how can we manipulate this complex system to 
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